Cat. No.: ROOC-2603-CXX-005
Description: Pulmonary fibrosis represents an advanced stage of various lung diseases, characterized by fibroblast proliferation, excessive extracellular matrix deposition, and concomitant inflammatory damage and tissue destruction. A pulmonary fibrosis model has been established using primary tissue cultured in a microfluidic chip.
Price: Inquiry
Datasheet: Datasheet
| Advantages | This platform uniquely combines high physiological fidelity with experimental throughput, offering a valuable tool for the development of novel anti-fibrotic therapeutics. |
| Species | Human |
| Product Type | Organoid-on-a-Chip |
| Disease | Pulmonary Fibrosis |
| Applications | Supports mechanistic studies of pulmonary fibrosis pathogenesis and preclinical development of anti-fibrotic therapies. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.
